GGrantIndex
← Leaderboards

David Scott Johnson

Gigagen, Inc.

$11,352,966
Attributed
$11,352,966
Total exposure
18
Grants
18
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $2.2M · FY201125
$2.5M$1.9M$1.3M$625K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$11,352,966 · 18

By mechanism

R44$8,523,041 · 6
R43$2,829,925 · 12

Top collaborators

No co-investigators on record.

Others in their field

Top investigators on “Small Business Innovation Research Grant

Research focus

Small Business Innovation Research GrantDoctor Of PhilosophyDiagnosticImmuneCapitalCellsTechnologySpecialistIn VitroUnited States National Institutes Of HealthScientistProduct DevelopmentSequoiaGenomicsAntibodiesNew TechnologyMolecularLibrariesMicrofluidicsBaseVariantProteinsInnovationPharmaceutical Preparations

Grant awards (26)

A Novel Lentivector for Enhanced In Vivo Delivery of T Cell Receptors for Cell Therapy for Stage IV Melanoma$400,000
R44 · FY2025 · CA · contact PI
In vivo Sickle Cell Disease Gene Therapy Using a Novel Virus Like Particle$300,000
R43 · FY2024 · HL · contact PI
In vivo Gene Delivery to Regulatory T Cells to Drastically Reduce the Cost of Regulatory T Cell Therapy$300,000
R43 · FY2023 · AI · contact PI
Delivery of Full Length Dystrophin to Muscle Cells for DMD Gene Therapy$295,294
R43 · FY2023 · AR · contact PI
Production Technology for Recombinant Intravenous Immunoglobulin$1,000,000
R44 · FY2019 · AI · contact PI
Production Technology for Recombinant Intravenous Immunoglobulin$1,000,000
R44 · FY2018 · AI · contact PI
Next-Generation Antibody Discovery and Development Technology$209,825
R44 · FY2018 · CA · contact PI
Production Technology for Recombinant Intravenous Immunoglobulin$1,000,000
R44 · FY2017 · AI · contact PI
Recombinant Hyperimmune Gammaglobulin for Primary Immunodeficiency$749,659
R44 · FY2017 · AI · contact PI
Next-Generation Antibody Discovery and Development Technology$480,577
R44 · FY2017 · CA · contact PI
Next-Generation Antibody Discovery and Development Technology$879,836
R44 · FY2016 · CA · contact PI
Recombinant Hyperimmune Gammaglobulin for Primary Immunodeficiency$750,198
R44 · FY2016 · AI · contact PI
Commercialization of an Advanced Technology for T Cell Receptor Analysis and Engineering$40,000
R43 · FY2016 · AI · contact PI
Molecular Kits and Software for Lymphoid Malignancy Work-ups$256,506
R44 · FY2015 · CA · contact PI
Production Technology for Recombinant Intravenous Immunoglobulin$225,000
R43 · FY2015 · AI · contact PI
An Advanced Tool for Immune Cell Analysis Using Microfluidics$225,000
R43 · FY2015 · AI · contact PI
Recombinant Hyperimmune Gammaglobulin for Pneumococcal Disease$224,819
R43 · FY2015 · AI · contact PI
Cloud-Based Bioinformatics for Immune Repertoire Analysis$5,000
R44 · FY2015 · HG · contact PI
Molecular Kits and Software for Lymphoid Malignancy Work-ups$656,240
R44 · FY2014 · CA · contact PI
B Cell Repertoire Molecular Platform for Antibody Drug Discovery$249,077
R43 · FY2014 · CA · contact PI
Therapeutic Antibody Discovery from Pancreatic Cancer B Cell Repertoires$217,469
R43 · FY2014 · CA · contact PI
Cloud-Based Bioinformatics for Immune Repertoire Analysis$1,135,200
R44 · FY2013 · HG · contact PI
Bioinformatics Data "Cleaning" for Immune Repertoire Sequencing$205,650
R43 · FY2012 · CA · contact PI
Massively Parallel Haplotyping$189,550
R43 · FY2012 · HG · contact PI
Cloud-Based Analysis of TCR Repertoire Sequencing Data$156,450
R43 · FY2012 · HG · contact PI
Innovative Molecular Platform for Prenatal Diagnostics$201,616
R43 · FY2011 · HD · contact PI